Bonny G. Lui
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Messenger RNA delivery of a dual CD25/CD122 affinity-tuned IL-2 variant prolongs exposure and potentiates antitumor T cell immunity.
Journal: Science advances
Published: September 04, 2026
Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.
Journal: Open forum infectious diseases
Published: October 28, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children.
Journal: Open forum infectious diseases
Published: July 04, 2025
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity.
Journal: Cell reports
Published: March 17, 2023
Early computational detection of potential high-risk SARS-CoV-2 variants.
Journal: Computers in biology and medicine
Published: November 18, 2022
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice.
Journal: Science immunology
Published: November 15, 2022
Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5.
Journal: Science immunology
Published: September 20, 2022
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.
Journal: Science immunology
Published: June 02, 2022
Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
Journal: Science (New York, N.Y.)
Published: January 18, 2022
BNT162b vaccines protect rhesus macaques from SARS-CoV-2.
Journal: Nature
Published: September 01, 2020
Last Updated: 09/26/2026